DRW Securities, LLC
Broker-DealerPosition in ACAD — Acadia Pharmaceuticals Inc
CIK 1481986
CHICAGO, IL
Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$432,908
+$232,724 QoQ
Shares Held
17,111
+90.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#203
of 346 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DRW Securities, LLC holds $13,086,376 across 39 Biotechnology names. ACAD ranks #4 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CNTN |
Canton Strategic Holdings, Inc.
|
1,724,618 | $4,863,422 | |
| 2 | ARGX |
Argenx SE
|
947 | $878,598 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
1,731 | $493,283 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
17,111 | $432,908 | |
| 5 | SVRA |
Savara Inc
|
69,638 | $428,970 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
22,294 | $378,329 | |
| 7 | IMNM |
Immunome Inc.
|
17,686 | $374,766 | |
| 8 | INCY |
Incyte Corp
|
3,100 | $351,416 |
All Filings in ACAD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $432,908 | 17,111 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $200,184 | 8,993 | Shares | Other | 2026-05-13 | |
| 2025-06-30 | $216,713 | 10,047 | Shares | Other | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||